TRAF3/STAT6 axis regulates macrophage polarization and tumor progression

Area of Science:

• Immunology
• Cancer Biology
• Molecular Biology

Background:

• Tumor-associated macrophages (TAMs) often exhibit an M2 phenotype, hindering anti-tumor immunity.
• Reprogramming TAMs to an M1 phenotype is a promising cancer therapy strategy.
• The precise role of TRAF3 (TNF receptor-associated factor 3) in TAM polarization remains unclear.

Purpose of the Study:

• To investigate the role of TRAF3 in macrophage polarization.
• To elucidate the molecular mechanisms by which TRAF3 influences TAM phenotype.
• To assess the therapeutic potential of targeting TRAF3 in cancer.

Main Methods:

• Macrophage polarization assays (M1/M2 markers).
• Quantitative ubiquitomics and Western blotting to analyze protein ubiquitination.
• Luciferase and site-directed mutagenesis assays to study STAT6 activation.
• In vivo B16 melanoma mouse model to evaluate tumor growth and metastasis.

Main Results:

• TRAF3 ablation enhanced M1 markers (iNOS, FGR, SLC4A7) and reduced M2 markers (CD206, CD36, ABCC3).
• TRAF3 deficiency promoted LPS-induced M1 polarization and inhibited IL-4-induced M2 polarization.
• TRAF3 was found to promote STAT6 ubiquitination and transcriptional activity, particularly at the K450 residue.
• Myeloid-specific TRAF3 deficiency suppressed tumor growth and lung metastasis in a mouse model.

Conclusions:

• TRAF3 plays a critical role in promoting M2 macrophage polarization.
• TRAF3 regulates M2 polarization by enhancing STAT6 ubiquitination at the K450 site.
• Targeting TRAF3 may represent a novel therapeutic strategy for suppressing tumor progression and metastasis.